{"database": "lobbying", "table": "lobbying_activities", "rows": [[795464, "f4ba6722-1cc6-43be-a4a9-0d478c8e0fa0", "Q2", "THE RUSSELL GROUP, INC.", 22688, "GENERIC PHARMACEUTICAL ASSOCIATION", 2009, "second_quarter", "PHA", "Issues relative to generic pharmaceuticals and generic biologics;\nH.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); \nH.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill)", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2009-07-17T09:03:09-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["795464"], "units": {}, "query_ms": 0.2961360150948167, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}